Your browser doesn't support javascript.
loading
Casivirimab/Imdevimab Effect on COVID-19 Outcome and Reinfection in a Real-World SARS-COV-2 Variant Transition Period Setting.
Tzitzi, Evanthia; Pyrpasopoulou, Athina; Kalmoukos, Panagiotis; Kefas, Aristeidis; Kyrana, Zacharenia; Doukelis, Panagiotis; Varouktsi, Anna; Imprialos, Kostas; Doumas, Michail.
Afiliação
  • Tzitzi E; COVID Department, Hippokration Hospital Thessaloniki, Thessaloniki, Greece.
  • Pyrpasopoulou A; COVID Department, Hippokration Hospital Thessaloniki, Thessaloniki, Greece.
  • Kalmoukos P; COVID Department, Hippokration Hospital Thessaloniki, Thessaloniki, Greece.
  • Kefas A; COVID Department, Hippokration Hospital Thessaloniki, Thessaloniki, Greece.
  • Kyrana Z; COVID Department, Hippokration Hospital Thessaloniki, Thessaloniki, Greece.
  • Doukelis P; COVID Department, Hippokration Hospital Thessaloniki, Thessaloniki, Greece.
  • Varouktsi A; COVID Department, Hippokration Hospital Thessaloniki, Thessaloniki, Greece.
  • Imprialos K; COVID Department, Hippokration Hospital Thessaloniki, Thessaloniki, Greece.
  • Doumas M; COVID Department, Hippokration Hospital Thessaloniki, Thessaloniki, Greece.
Monoclon Antib Immunodiagn Immunother ; 42(1): 48-50, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36757301
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Monoclon Antib Immunodiagn Immunother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Grécia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Monoclon Antib Immunodiagn Immunother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Grécia